SUCCINCT: An Open-label, Single-arm, Non-randomised, Phase 2 Trial of Gemcitabine and Cisplatin Chemotherapy in Combination with Sunitinib as First-line Treatment for Patients with Advanced Urothelial Carcinoma

Gemcitabine and cisplatin chemotherapy (GC regimen) represents a standard treatment for advanced urothelial carcinoma. We performed an open-label, single-arm, non-randomised, phase 2 trial evaluating the addition of sunitinib to standard GC chemotherapy (SGC regimen). Overall, 63 treatment-naïve par...

Descripción completa

Detalles Bibliográficos
Autores principales: Geldart, Thomas, Chester, John, Casbard, Angela, Crabb, Simon, Elliott, Tony, Protheroe, Andrew, Huddart, Robert A., Mead, Graham, Barber, Jim, Jones, Robert J., Smith, Joanna, Cowles, Robert, Evans, Jessica, Griffiths, Gareth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2015
Materias:
Platinum Priority – Brief Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410296/
https://www.ncbi.nlm.nih.gov/pubmed/25465968
http://dx.doi.org/10.1016/j.eururo.2014.11.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410296/
https://www.ncbi.nlm.nih.gov/pubmed/25465968
http://dx.doi.org/10.1016/j.eururo.2014.11.003

Ejemplares similares